Exin Therapeutics says an AI agent chose a gene therapy and guided its injection into a mouse brain

The company's account says humans did the surgery and a veterinarian approved each irreversible step; seizure results are not reported and there is no paper.

Read at India Today

More from Snape Report

Nasdaq slides 2.9% as Intel has its worst day since the 1970s and chip stocks fall
S&P revises Meta's outlook to negative over AI capital spending and negative free cash flow
Intel shares fall 29%, their worst day since the 1970s, cutting about $12 billion from the US government's stake
Mistral releases open weights for Mistral Large 4, its 1-trillion-parameter model
Google's Suncatcher satellite returns the first AI response from a data-centre TPU in orbit
FDA grants accelerated approval to Inovio's Voceryq, the first US plasmid DNA immunotherapy, for adult RRP
Anthropic renames Claude Max 20x to Ultra and drops the 5-hour limit for verified Ultra accounts
OpenAI reorganizes its Model Spec around five core values

Front page →